Synthesis method of NH2-PEG4-RK (Dde)-OH
The problem of poor purity of NH2-PEG4-RK(Dde)-OH crude product in solid phase synthesis was solved through the segmented synthesis method, and the preparation of high purity and high yield was achieved, the process was simplified, and it was suitable for industrial production.
Patent Information
- Application Number
- CN202411432285.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-14
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-10-14
AI Technical Summary
In the prior art, when NH2-PEG4-RK(Dde)-OH is prepared by solid phase synthesis, difficult sequences are easily formed, resulting in poor purity of crude products and similar structurally many impurities, difficult preparation and purification, and affecting product purity and yield.
NH2-PEG4-RK(Dde)-OH is synthesized by two-stage or three-stage method, and the specific carbon end sites and synthetic fragments are used to couple the condensant to improve product purity and yield.
The preparation of NH2-PEG4-RK(Dde)-OH with high purity and high yield is achieved, which simplifies the process and is suitable for industrial production.
Smart Images

Figure CN118955625A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of organic synthesis, and particularly to an NH 2 -PEG 4 -RK(Dde)-OH synthesis method. Background Art
[0002] Human epidermal growth factor receptor 2 (HER 2 ) is a tyrosine kinase receptor and a member of the epidermal growth factor receptor (EGFR) family. 2 The amplification and overexpression of HER are closely related to the high invasiveness, high recurrence and high mortality of tumors. It is highly expressed to varying degrees in a variety of malignant tumors (such as breast cancer, gastric cancer, lung cancer, etc.) and is an important target for molecular imaging diagnosis and targeted therapy (monoclonal antibodies, antibody-drug conjugates, etc.). 2 The carcinogenic mechanisms of TNF-α mainly include: promoting tumor cell proliferation, increasing tumor cell invasiveness, inhibiting tumor cell apoptosis and promoting tumor angiogenesis and lymphangiogenesis, thus providing favorable conditions for tumor growth and metastasis.
[0003] Currently, the commonly used HER 2 Targeting ligands include antibodies, small molecule peptides, or proteins that specifically bind to receptors. In cancer treatment, peptides can be used as targeting ligands to specifically deliver cytotoxic drugs to the tumor vasculature, tumor microenvironment, or cancer cells. On the other hand, peptides can also be delivered intracellularly to target cancer-specific upregulated transcription factors, oncogenes, or enzymes. In diagnostic imaging, short peptides have good penetration and can penetrate deep into solid tumors. They have short metabolic cycles, can be quickly cleared from the circulation, and have the advantages of low toxicity. Through the efficient peptide screening method of in situ single-cell sequencing on microarrays, two new octapeptides, YLFFVFER (H6) and KLRLEWNR (H10), have attracted people's attention. The probes of H6 and H10 have also shown that they can be used in HER 2 High specificity and affinity in positive tumor tissues. The KD of H6 and H10 were 6.70×10 -8 mol / L and 3.04×10 -8 mmol / L. The plasma half-life of H6 is 17 minutes, and that of H10 is 13 minutes. Due to the shorter half-life of H10, H10 may be cleared from the blood faster than H6 and have lower toxicity.
[0004] The structure of KLRLEWNR (H10) is: lysine-leucine-arginine-leucine-glutamic acid-tryptophan-asparagine-arginine, and the structural formula is as follows:
[0005] The existing KLRLEWNR (H10) modification method is: structurally modifying the H10 peptide chain, retaining the integrity of the peptide chain, exchanging the C and N ends, and coupling a PEG long chain with an amino group at the end to the arginine, which can not only increase the water solubility of the entire peptide chain, but also enable the targeted compound to be coupled with anticancer drugs as an intermediate to achieve precise treatment of tumors. The structure of the modified compound is as follows:
[0006] The structural formula of this compound is: NH 2 -PEG 4 -Arg-Asn-Trp-Glu-Leu-Arg-Leu-Lys(Dde)-OH; English name: N 2 -(1-amino-3,6,9,12-tetraoxapentadecan-15-oyl)-L-arginyl-L-asparaginyl-L-tryptophyl-L-glutamyl-L-leucyl-L-arginyl-L-leucyl-N 6 -[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]-L-lysine; Chinese name: N 2 -(1-amino-3,6,9,12-tetrahydropentadecan-15-oxo)-L-arginyl-L-asparaginyl-L-tryptophanyl-L-glutamyl-L-leucine-L-arginyl-L-leucine-N 6 -[1-(4,4-dimethyl-2,6-dioxocyclohexylene)ethyl]-L-lysine; abbreviation: NH 2 -PEG 4 -RK(Dde)-OH.
[0007] NH 2 -PEG 4 The crude product of -RK(Dde)-OH has low purity and many impurities. Some impurities have similar structures to the main component, which leads to similar chromatographic behavior to the main component, thus increasing the difficulty of separation and requiring multiple HPLC preparation and purification. 2 -PEG 4-RK(Dde)-OH contains an Asn residue. During the preparation and purification process, it was found that Asn was hydrolyzed to form Asp. After a series of process improvements, such as increasing the feed ratio of protected amino acids, changing the type of condensing agent, and reducing the degree of substitution of resins, NH 2 -PEG 4 The purity of crude -RK(Dde)-OH was not significantly improved. Summary of the invention
[0008] The present invention aims to 2 -PEG 4 -RK(Dde)-OH is difficult to synthesize, and a synthesis method for improving the purity of the product is provided.
[0009] To achieve the above purpose, the technical solution provided by the present invention is: ANH 2 -PEG 4 -RK(Dde)-OH synthesis method, using the segmented synthesis method to synthesize NH 2 -PEG 4 -RK(Dde)-OH, the segmented synthesis method is a two-stage method or a three-stage method; the two-stage method uses 5-Glu as a carbon terminal site to make NH 2 -PEG 4 -RK(Dde)-OH was synthesized via two synthetic fragments: fragment Wang-(9-6)-NH 2 and fragment Fmoc-(1-5)-OH; The three-stage method uses 3-Asn and 6-Leu as the two carbon terminal sites, respectively, so that NH 2 -PEG 4 -RK(Dde)-OH was synthesized through three synthetic fragments: fragment Wang-(9-7)-NH 2 , fragment Fmoc-(4-6)-OH and fragment Fmoc-(1-3)-OH; The synthetic fragments are coupled via a condensing agent.
[0010] In the two-stage method, the reactant is the fragment Wang-(9-6)-NH 2 , fragment Fmoc-(1-5)-OH, HATU, HOAt and DIPEA, preferably, the reaction molar ratio is fragment 1: 1.5: 2.0: 2.0: 4.0; in the three-stage method, the reactant is the fragment Wang-(9-7)-NH 2, fragment Fmoc-(4-6)-OH, fragment Fmoc-(1-3)-OH, HATU, HOAt, DIPEA, preferably, the reaction molar ratio is 1:1.5:1.5:2.0:2.0:4.0; after the reaction, the product is eluted with Wang resin lysis solution, preferably, the Wang resin lysis solution is TFA:TIPS:H 2 O=95:2.5:2.5, v / v, mix well, and freeze to 5±5°C; the crude product obtained by the reaction was purified by HPLC.
[0011] The fragment Wang-(9-6)-NH 2 The synthesis method is to react Wang-Lys(Dde) with protected amino acid, HBTU and DIPEA, preferably, the reaction molar ratio is 1.0:3.0:3.0:3.0.
[0012] The synthesis method of Wang-Lys(Dde) is to react Wang resin with Fmoc-Lys(Dde)-OH, HOBt, DIC and DMAP. Preferably, the reaction molar ratio is 1.0:2.5:2.5:2.5:0.05.
[0013] The synthesis method of the fragment Fmoc-(1-5)-OH is to react CTC-Glu(OtBu) with protected amino acid, HBTU and DIPEA, preferably, the reaction molar ratio is 1.0:3.0:3.0:3.0; after the reaction, the product is eluted with CTC resin lysis solution, preferably, the CTC resin lysis solution is TFA:DCM=1:99, v / v, mixed evenly, and frozen to 5±5°C.
[0014] The synthesis method of CTC-Glu(OtBu) is to react CTC resin with Fmoc-Glu(OtBu)-OH and DIPEA, preferably, the reaction molar ratio is 1.0:2.0:4.0.
[0015] The fragment Wang-(9-7)-NH 2 The synthesis method is to react Wang-Lys(Dde) with protected amino acid, HBTU and DIPEA, preferably, the reaction molar ratio is 1.0:3.0:3.0:3.0.
[0016] The synthesis method of the fragment Fmoc-(4-6)-OH is to react CTC-Leu with a protected amino acid, HBTU, and DIPEA, preferably, the reaction molar ratio is 1.0:3.0:3.0:3.0; after the reaction, the product is eluted with a CTC resin lysis solution, preferably, the CTC resin lysis solution is TFA:DCM=1:99, v / v, mixed evenly, and frozen to 5±5°C.
[0017] The synthesis method of CTC-Leu is to react CTC resin with Fmoc-Leu-OH and DIPEA, preferably, the reaction molar ratio is 1.0:2.0:4.0.
[0018] The synthesis method of the fragment Fmoc-(1-3)-OH is to react CTC-Asn(Trt) with a protected amino acid, HBTU and DIPEA, preferably, the reaction molar ratio is 1.0:3.0:3.0:3.0; after the reaction, the product is eluted with a CTC resin lysis solution, preferably, the CTC resin lysis solution is TFA:DCM=1:99, v / v, mixed evenly, and frozen to 5±5°C.
[0019] The synthesis method of CTC-Asn(Trt) is to react CTC resin with Fmoc-Asn(Trt)-OH and DIPEA, preferably, the reaction molar ratio is 1.0:2.0:4.0.
[0020] Compared with the prior art, the present invention has the following beneficial effects: The present invention proposes a NH 2 -PEG 4 The segmented synthesis method of -RK(Dde)-OH can solve the problem of preparing NH 2 -PEG 4 -RK(Dde)-OH is prone to form difficult sequences, and missing peptides and misconnected peptides are easily formed during the coupling process, resulting in poor purity of the crude product and a large number of structurally similar impurities, making preparation and purification difficult, affecting product purity and yield.
[0021] The present invention studies NH 2 -PEG 4 -RK(Dde)-OH has been synthesized in various stages, and the most suitable 2 -PEG 4 -RK(Dde)-OH synthesis stepwise synthesis method; the process of the method is simple, and the product purity and yield are high, suitable for NH 2 -PEG 4 Industrial production of -RK(Dde)-OH. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 : NH for this application 2 -PEG 4 -RK(Dde)-OH segmented synthesis site. DETAILED DESCRIPTION
[0023] The above contents of the present invention are further described in detail below in the form of embodiments, but this should not be understood as the scope of the above subject matter of the present invention being limited to the following embodiments, and all technologies realized based on the above contents of the present invention belong to the scope of the present invention.
[0024] The test methods used in the following examples are all conventional methods unless otherwise specified, and the reagents, methods and equipment used are all conventional reagents, methods and equipment in the art unless otherwise specified.
[0025] The abbreviations and notes involved in the present invention are shown in Table 1: Table 1 Abbreviations
[0026] The protected amino acid in the present application is selected from: Fmoc-Lys(Dde)-OH, Fmoc-Leu-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Trp(Boc)-OH, FmocAsn(Trt)-OH, and Fmoc-PEG 4 -OH.
[0027] To solve the problem of preparing NH 2 -PEG 4 -RK(Dde)-OH is prone to form difficult sequences, and it is easy to form missing peptides and misconnected peptides during the coupling process. The crude product has poor purity, many structurally similar impurities, and is difficult to prepare and purify, which affects the purity and yield of the product. This application proposes a NH 2 -PEG 4 -RK(Dde)-OH stepwise synthesis method.
[0028] The solid phase synthesis one-by-one connection method, the improved solid phase synthesis one-by-one connection method and the segmented synthesis method of the present invention are introduced below: (I) Preparation of NH by solid phase synthesis and ligation 2 -PEG 4 -RK(Dde)-OH: First, CTC-Lys(Dde) resin was prepared and coupled with Fmoc-Leu-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Leu-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Trp(Boc)-OH, FmocAsn(Trt)-OH, Fmoc-Arg(Pbf)-OH, and Fmoc-PEG 4-OH, to obtain: CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG 4 -NH 2 Resin, 95% TFA cleavage, NH 2 -PEG 4 -RK(Dde)-OH crude product was purified by HPLC and freeze-dried to obtain NH 2 -PEG 4 -RK(Dde)-OH refined product.
[0029] Solid-phase synthesis of NH 2 -PEG 4 The process route of -RK(Dde)-OH is:
[0030] During the experiment, it was found that the NH obtained by conventional solid phase synthesis and connection method was 2 -PEG 4 The crude purity of -RK(Dde)-OH is 60-70%, with many impurities. Some impurities may have structural similarities with the main component, which makes their chromatographic behavior similar to that of the main component, increasing the difficulty of separation. It takes multiple HPLC preparations and purifications to obtain a refined product with a purity of >95% and a single impurity of <3.0%. In addition, the polypeptide contains Asn residues. During the multiple preparation and purification processes, Asn was found to be hydrolyzed to form Asp. Solid-phase synthesis and one-by-one connection method to prepare NH 2 -PEG 4 The specific test process of -RK(Dde)-OH is shown in Comparative Example 1.
[0031] (II) Improved solid phase synthesis and one-by-one ligation method for preparing NH 2 -PEG 4 -RK(Dde)-OH: For the above conventional solid phase synthesis, the NH 2 -PEG 4 -RK(Dde)-OH problems were improved and optimized using the following process conditions: (1) Increase the feed ratio of protected amino acid and change the feed ratio of CTC-Lys(Dde) resin (substitution degree: 0.70 mmol / g): protected amino acid: HBTU: DIPEA from 1:3:3:3 to 1:5:5:5; (2) Changing the type of condensing agent, such as using HOBt-PyBOP-DIPEA or HATU-HOAt-DIPEA as condensing agent instead of the original HBTU-DIPEA condensing agent; (3) Reduce the degree of substitution of the resin, such as using CTC-Lys(Dde) (substitution degree 0.4-0.5 mmol / g).
[0032] According to the above improvement plan, a series of comparative tests were carried out. The test results are as follows: NH 2 -PEG 4 The purity of crude -RK(Dde)-OH is less than 80%. After HPLC preparation, the purity of refined product is greater than 95%, and the total yield is 40-50%.
[0033] It can be seen that the change of process parameters does not affect the NH 2 -PEG 4 The purity of the crude -RK(Dde)-OH product was significantly improved, but the purity was still less than 80%. This may be related to the Dde group in CTC-Lys(Dde). The Dde group can be selectively removed under the condition of 2% hydrazine hydrate. It may not be stable under certain conditions, especially in an alkaline environment. The Dde group may react, causing its protective effect to weaken or disappear.
[0034] Piperidine used in the removal of the Fmoc group and DIPEA used in the coupling of protected amino acids are both organic bases. The instability of the Dde group will inevitably produce a series of by-products. Six amino acids with protected groups need to be coupled to obtain CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG 4 -NH 2 In the coupling process, the amino acids with protective groups have strong hydrophobicity, and the reactivity of the carbon end may be affected, which may form a "difficult sequence" in the coupling process. In the process of coupling one by one, missing peptides and misconnected peptides are easily formed. 2 -PEG 4 The specific test process of -RK(Dde)-OH is shown in Comparative Examples 2 to 5.
[0035] (III) This application studies NH 2 -PEG 4 -RK(Dde)-OH has various segmented synthesis methods, as shown in Table 2, and relatively stable Leu, Glu, and Asn in the 9-peptide chain are selected as the carbon terminal sites, such as Figure 1 shown.
[0036] Table 2 Segmentation sites
[0037] This application investigated five segmentation methods, A, B, C, D, and E, as shown in Table 3. It was found that the segmentation method for synthesizing NH 2 -PEG 4 -RK(Dde)-OH is a very effective method to improve the purity of the product.
[0038] By testing the products obtained by different segmentation methods, it was found that the following segmentation method is better: using 5-Glu as a carbon terminal site to form a two-stage method, the synthesis of the two-stage method is composed of the fragment Wang-(9-6)-NH 2 and the fragment Fmoc-(1-5)-OH; 3-Asn and 6-Leu are used as the two carbon-terminal sites, forming a three-stage method. The synthesis of the three-stage method is composed of the fragment Wang-(9-7)-NH 2 , fragment Fmoc-(4-6)-OH and fragment Fmoc-(1-3)-OH.
[0039] That is, segmentation method B and segmentation method D have advantages; among them, segmentation method B, the method of disconnecting at the 5-Glu position has a higher product purity, and the 4+5 two-stage method is simpler, and the purity of the obtained crude product is greater than 90%; at the same time, by purifying the crude products obtained by different segmentation methods, the purity of the purified refined product is greater than 99.0%, the single impurity is less than 0.5%, and the total yield is greater than 75%. This method has low production cost, simple process and easy operation, and is most suitable for NH 2 -PEG 4 Industrial production of -RK(Dde)-OH.
[0040] Table 3 Segmentation method
[0041] NH of this application 2 -PEG 4 The specific experimental process of the segmented synthesis method of -RK(Dde)-OH is shown in Examples 1 to 5.
[0042] The present invention is further described in detail below in conjunction with specific embodiments and comparative examples: Comparative Example 1 Preparation of NH by solid phase synthesis and connection 2 -PEG 4 -RK(Dde)-OH The material molar ratio of CTC-Lys(Dde) resin (substitution degree: 0.70 mmol / g), protected amino acid, HBTU, and DIPEA is 1:3:3:3.
[0043] Preparation of intermediate CTC-Lys(Dde), feed amounts are shown in Table 4: Table 4 Preparation and Feeding Amount of CTC-Lys(Dde) in Comparative Example 1
[0044] Process: Washing and swelling: Weigh CTC resin and add it to the peptide solid phase synthesis tube. Measure N,N-dimethylformamide (DMF) and add it to the peptide solid phase synthesis tube (the amount of solvent is based on the uniform dispersion of the resin in the solvent. Generally, the amount of solvent is 4.0-6.0eq of the resin, the same below). Wash 3 times (N 2 Bubble, 1 min each time, and remove after washing); DMF, N 2 Bubble for 60 minutes, and drain the liquid after full swelling; Coupling: CTC resin molar mass N 0 As the base, weigh Fmoc-Lys(Dde)-OH, take an appropriate amount of DMF, add them to a beaker, stir to dissolve, and add them to the peptide solid phase synthesis tube; weigh DIPEA and add it to the peptide solid phase synthesis tube. The coupling reaction lasts 2.0~3.0h, the reaction solution is removed, DMF is added, and washed 3 times (N 2 Bubbling, 1 min each time, after finishing, drain the liquid); Blocking: Add an appropriate amount of dichloromethane (DCM): methanol: DIPEA = 3:1:1 mixture to the peptide solid phase synthesis tube, and block the reaction twice (N 2 Bubbling, 10 minutes each time, after finishing, drain the liquid); Shrinkage: Add appropriate amount of methanol to the peptide solid phase synthesis tube and shrink it 3 times (N 2 Bubbling, the time is 5min, 5min, 10min respectively, after the end, drain the liquid); Drying: Dry with nitrogen flow for 4.0~5.0h until the resin particles are no longer sticky and are in the form of quicksand; CTC-Lys(Dde) resin was obtained, and the substitution degree of CTC-Lys(Dde) resin was detected to be 0.70 mmol / g.
[0045] NH 2 -PEG 4 Preparation of crude -RK(Dde)-OH, feed amounts are shown in Table 5: Table 5 Comparative Example 1 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0046] Process: Washing and swelling: Weigh CTC-Lys(Dde) resin, add it to the peptide solid phase synthesis tube, weigh N,N-dimethylformamide (DMF) and add it to the peptide solid phase synthesis tube (the amount of solvent is based on the resin being evenly dispersed in the solvent. Generally, the amount of solvent is 4.0-6.0eq of the resin, the same below), wash twice (N 2 Bubble, 1 min each time, and remove after washing); DMF, N 2 Bubble for 30 minutes, and drain the liquid after full swelling; Coupling Fmoc-Leu-OH: Removal of Fmoc group and color development: Add 20% piperidine solution to the peptide solid phase synthesis tube and remove Fmoc twice (N 2 The bubbling time was 5min and 7min respectively, and the liquid was drained after the end), and washed with DMF 6 times (N 2 Bubble, 1 min each time, remove after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3 min; observe whether color is developed), detect the color change of resin; activation, coupling, color development, washing: on a synthetic scale N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Leu-OH (3.0eq), HBTU (3.0eq); add to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (3.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; room temperature 20-35℃, coupling reaction 0.5~1.0 hour; Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min; observe whether color is developed to determine whether the reaction is complete; if color is developed, continue coupling for 0.5 hour); drain the reaction solution, wash with DMF 3 times (N 2 Bubble for 1 min each time and remove after washing).
[0047] Repeat the above steps to couple the following 6 amino acid fragments and Fmoc-PEG according to the dosage in the feed list. 4 -Propionic acid fragment: coupling Fmoc-Arg(Pbf)-OH; coupling Fmoc-Leu-OH; coupling Fmoc-Glu(OtBu)-OH; coupling Fmoc-Trp(Boc)-OH; coupling Fmoc-Asn(Trt)-OH; coupling Fmoc-Arg(Pbf)-OH; coupling Fmoc-PEG 4 - Propionic acid; Removal of Fmoc group and color development: same as before; Shrinkage: Add appropriate amount of methanol to the peptide solid phase synthesis tube and shrink it 3 times (N 2Bubbling, the time is 5min, 5min, 10min respectively, after the end, drain the liquid); Drying: Dry with nitrogen flow for 4.0-5.0 hours until the resin particles are no longer sticky and are in the form of quicksand, and CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG is obtained. 4 -NH 2 Resin; Cleavage: Cleavage solution preparation: According to the ratio of 10ml / 1g resin, prepare cleavage solution: (TFA: TIPS: H 2 O = 95: 2.5: 2.5 v / v), mix well, and freeze to 5 ± 5 °C; Pre-freeze ether: prepare the required ether according to the ratio of 70ml / 1g resin, freeze it in the freezer for more than 2 hours, and set aside; add CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG into the reaction bottle 4 -NH 2 The resin was slowly added with the prepared pre-cooled lysis solution under stirring, fully stirred, and the lysis reaction was carried out at room temperature of 20-30°C for 2.0-3.0 hours; filtered and the filtrate was collected; the filter cake was washed once with a small amount of lysis solution; the filtrate was combined; ice-cold ether (4-5 ml ether / 1 ml lysis solution) was added to the reaction bottle, and the filtrate was slowly added under stirring to precipitate the product, stirred for 20 minutes, filtered, and fully washed with appropriate amount of ice-cold ether for more than 3 times; the obtained product was vacuum dried at room temperature of 20-30°C for 6.0-7.0 hours to obtain NH 2 -PEG 4 -RK(Dde)-OH crude product, crude yield 112.27%, crude purity 63.775%.
[0048] NH 2 -PEG 4 Preparation of -RK(Dde)-OH refined product, feed amount see Table 6: Table 6 Comparative Example 1 NH 2 -PEG 4 -RK(Dde)-OH refined product preparation feed amount
[0049] Purification method: Chromatographic column: DEVOTE Dasiogel C18 250mm*100mm, 8μm; Mobile phase: Mobile phase A: 0.1% TFA aqueous solution; Mobile phase B: acetonitrile; Detection wavelength: 220nm; Flow rate: 150ml / min; Purification gradient see Table 7: Table 7 Comparative Example 1 Purification Gradient
[0050] Process: NH 2 -PEG 4 -RK(Dde)-OH crude product was dissolved and filtered: NH 2 -PEG 4 -RK(Dde)-OH crude product was ultrasonically dissolved in 400 ml of diluent (90% mobile phase A-10% mobile phase B); a 0.22 µm microporous glass fiber filter was placed in the funnel, fully wetted, and NH 2 -PEG 4 -RK(Dde)-OH crude solution, connect the vacuum pump, open the control valve, filter, and replace the filter paper according to the actual situation; the last NH 2 After the crude solution of -PEG4-RK(Dde)-OH was filtered, 100 ml of diluent was added to the filter and filtered. 2 -PEG 4 -RK(Dde)-OH crude solution was combined; sample loading: NH 2 -PEG 4 -RK(Dde)-OH crude solution was loaded; elution: linear gradient elution was performed according to the purification gradient; sample collection: target peaks (NH 2 -PEG 4 -RK(Dde)-OH retention time is about 46min), and the preparation chromatogram is saved; merge: merge the samples with purity less than 95.0% into a purer sample; concentrate: merge and concentrate the sample fractions with purity greater than 95.0%; freeze-dry: divide the merged target peptide solution into freeze-drying trays, each tray is 1.0~1.5 thick cm; put the product into the box, lock the box door, quickly freeze the product to below -45℃ and keep it warm for 2 hours, turn on the vacuum pump to evacuate the front box, the vacuum degree is <50Pa, and sublimate according to the following curve: set the heat transfer oil to 0℃ in 2 hours and keep it for more than 12 hours; set the heat transfer oil to 25℃ in 2 hours and keep it for more than 6 hours; release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure; sampling and packaging: release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure; open the box door and quickly take out the freeze-dried plate from the box; immediately take samples according to the sampling operation procedures after leaving the box; transfer the drugs into low-density ethylene bottles for drug packaging, and calculate CTC-Lys(Dde)→NH 2 -PEG 4 The yield of the refined product of -RK(Dde)-OH is 42.06%. The product is labeled, sealed and stored in a freezer. The purity of the refined product is 94.680%.
[0051] Comparative Example 2 Improved solid phase synthesis and one-by-one connection method for preparing NH 2 -PEG 4 -RK(Dde)-OH The material molar ratio of CTC-Lys(Dde) resin (substitution degree: 0.70 mmol / g), protected amino acid, HBTU, and DIPEA is 1:5:5:5.
[0052] (1) The preparation of the intermediate CTC-Lys(Dde) was the same as that in Comparative Example 1.
[0053] (2) NH 2 -PEG 4 The preparation reaction of crude -RK(Dde)-OH was the same as that of Comparative Example 1, and the feeding amounts were shown in Table 8: Table 8 Comparative Example 2 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0054] The process is roughly the same as that of Comparative Example 1, except that the amount of amino acid fragments fed is increased and the amount of solvent is appropriately increased, wherein activation and coupling are carried out on a synthetic scale of N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Leu-OH (5.0eq), HBTU (5.0eq); add them to a beaker, take an appropriate amount of DMF, stir to dissolve, add DIPEA (5.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; at room temperature 20-35℃, couple the reaction for 0.5~1.0 hour to obtain CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG 4 -NH 2 Resin; cracking to obtain NH 2 -PEG 4 -RK(Dde)-OH crude product, crude product yield 110.90%, the crude product purity 66.751%.
[0055] (3) NH 2 -PEG 4 Preparation of refined RK(Dde)-OH The purification conditions were the same as those in Comparative Example 1, and the process was roughly the same as that in Comparative Example 1. The total yield (CTC-Lys(Dde)→NH 2 -PEG 4 -RK(Dde)-OH refined product): 43.75%, labeled, sealed, and frozen for storage. The purity of the refined product is; 95.244%.
[0056] Comparative Example 3 Improved solid phase synthesis and one-by-one connection method for preparing NH 2 -PEG 4 -RK(Dde)-OH The material molar ratio of CTC-Lys(Dde) resin (substitution degree: 0.70 mmol / g), protected amino acid, HOBT, PyBop, and DIPEA is 1:1.5:1.5:1.4:2.8.
[0057] (1) The preparation of the intermediate CTC-Lys(Dde) was the same as that in Comparative Example 1.
[0058] (2) NH 2 -PEG 4 The preparation reaction of crude -RK(Dde)-OH was the same as that of Comparative Example 1, and the feeding amounts were shown in Table 9: Table 9 Comparative Example 3 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0059] The process is roughly the same as that of Comparative Example 1, wherein activation and coupling are carried out on a synthetic scale of N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Leu-OH (1.50eq), HOBT (1.50eq), PyBop (1.40eq); add them to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (2.80eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; at room temperature 20-35℃, couple the reaction for 0.5~1.0 hour to obtain CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG 4 -NH 2 Resin; cracking to obtain NH 2 -PEG 4 -RK(Dde)-OH crude product, crude yield 113.96%, crude purity 68.527%.
[0060] (3) NH 2 -PEG 4 Preparation of refined RK(Dde)-OH The purification conditions were the same as those in Comparative Example 1, and the process was roughly the same as that in Comparative Example 1. The total yield (CTC-Lys(Dde)→NH 2 -PEG 4-RK(Dde)-OH refined product): 45.58%, label, seal and store in freezer; the purity of the refined product is 95.443%.
[0061] Comparative Example 4 Improved solid phase synthesis and one-by-one connection method for preparing NH 2 -PEG 4 -RK(Dde)-OH (1) The preparation of the intermediate CTC-Lys(Dde) was the same as that in Comparative Example 1.
[0062] (2) NH 2 -PEG 4 The preparation reaction of crude -RK(Dde)-OH was the same as that of Comparative Example 1, and the feeding amounts were shown in Table 10: Table 10 Comparative Example 4 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0063] The process is roughly the same as that of Comparative Example 1, wherein activation and coupling are carried out on a synthetic scale of N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Leu-OH (3.00eq), HATU (3.00eq), HOAT (3.60eq); add them to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (6.00eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; at room temperature 20-35℃, couple the reaction for 0.5~1.0 hour to obtain CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG 4 -NH 2 Resin; NH 2 -PEG 4 -RK(Dde)-OH crude product, crude yield 112.88%, crude purity 70.138%.
[0064] (3) NH 2 -PEG 4 Preparation of refined RK(Dde)-OH The purification conditions were the same as those in Comparative Example 1, and the process was roughly the same as that in Comparative Example 1. The total yield (CTC-Lys(Dde)→NH 2 -PEG 4 -RK(Dde)-OH refined product): 47.57%, label, seal and store in a freezer; the purity of the refined product is 95.477%.
[0065] Comparative Example 5 Improved solid phase synthesis and one-by-one connection method for preparing NH 2 -PEG 4 -RK(Dde)-OH The material molar ratio of CTC-Lys(Dde) resin (substitution degree, 0.43 mmol / g), protected amino acid, HBTU, and DIPEA is 1:3:3:3.
[0066] The preparation reaction of the intermediate CTC-Lys (Dde) is the same as that of Comparative Example 1, and the feed amounts are shown in Table 11: Table 11 Comparative Example 5 Preparation of Intermediate CTC-Lys(Dde) Feeding Amount
[0067] The process is substantially the same as that of Comparative Example 1; CTC-Lys (Dde) resin is obtained, and the substitution degree of CTC-Lys (Dde) resin is detected to be 0.43 mmol / g.
[0068] NH 2 -PEG 4 The preparation reaction of crude -RK(Dde)-OH was the same as that of Comparative Example 1, and the feed amounts were shown in Table 12: Table 12 Comparative Example 5 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0069] The process is roughly the same as that of Comparative Example 1; activation, coupling: based on the synthesis scale N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Leu-OH (3.00eq), HBTU (3.00eq); add them to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (3.00eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; at room temperature 20-35℃, couple the reaction for 0.5~1.0 hour to obtain CTC-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG 4 -NH 2 Resin; NH 2 -PEG 4 -RK(Dde)-OH crude product, crude yield 113.34%, crude purity 75.911%.
[0070] (3) NH 2 -PEG 4 Preparation of refined RK(Dde)-OH The purification conditions were the same as those in Comparative Example 1, and the process was roughly the same as that in Comparative Example 1. The total yield (CTC-Lys(Dde)→NH 2 -PEG 4 -RK(Dde)-OH refined product): 51.24%, labeled, sealed, and frozen for storage. The purity of the refined product is; 95.867%.
[0071] The solid phase synthesis of NH 2 -PEG 4 The results of the -RK(Dde)-OH method are summarized in Table 13: Table 13 All solid phase synthesis of NH 2 -PEG 4 -RK(Dde)-OH method results
[0072] Wherein, resin: CTC-Lys(Dde) resin; AA: protected amino acid.
[0073] From the above table, we can see that reducing the substitution degree of CTC-Lys(Dde) resin can increase NH 2 -PEG 4 -RK(Dde)-OH crude purity, but the crude purity is still <80%, and reducing the degree of substitution will inevitably increase production costs.
[0074] Example 1 Stepwise method A: Preparation of NH 2 -PEG 4 -RK(Dde)-OH Process route: Wang-(9-7)-NH 2 Preparation:
[0075] Preparation of Fmoc-(1-6)-OH:
[0076] NH 2 -PEG 4 Preparation of -RK(Dde)-OH:
[0077] Wang-(9-7)-NH 2 Preparation Preparation of intermediate Wang-Lys (Dde), feed amounts are shown in Table 14: Table 14 Example 1 Preparation of intermediate Wang-Lys (Dde) Feeding amount
[0078] Process: Washing and swelling: Weigh Wang resin and add it to the peptide solid phase synthesis tube. Measure N,N-dimethylformamide (DMF) and add it to the peptide solid phase synthesis tube (the amount of solvent is based on the uniform dispersion of the resin in the solvent. Generally, the amount of solvent is 4.0-6.0eq of the resin, the same below). Wash 3 times (N 2 Bubble, 1 min each time, and remove after washing); DMF, N 2 Bubble for 60 min, and drain the liquid after full swelling; coupling: Wang resin molar weight N 0 As the base, weigh Fmoc-Lys(Dde)-OH, HOBt, DMAP, take an appropriate amount of DMF, add it to a beaker, weigh DIC, add it to the beaker under stirring, activate it for 10 minutes, develop and clarify it, and add it to the peptide solid phase synthesis tube; couple the reaction for 7.0~8.0h, remove the reaction solution, add DMF, and wash 3 times (N 2 Bubble for 1 min each time, and drain the liquid after the end); Block: Add an appropriate amount of pyridine: acetic anhydride = 1:1 mixture to the peptide solid phase synthesis tube, and block the reaction twice (N 2 Bubble for 30 minutes each time, and then drain the liquid after the end); shrink: add appropriate amount of methanol to the peptide solid phase synthesis tube and shrink 3 times (N 2 Bubbling, the time is 5min, 5min, 10min respectively, and the liquid is drained after the end); Drying: nitrogen flow blowing drying for 4.0~5.0h, until the resin particles are no longer sticky and are in the form of quicksand; Wang-Lys(Dde) resin is obtained, and the substitution degree of Wang-Lys(Dde) resin is detected to be 0.67mmol / g.
[0079] (1.2) Preparation of Wang-(9-7)-NH 2 , feed amount see Table 15: Table 15 Example 1 Wang-(9-7)-NH 2 Preparation feed amount
[0080] Process: Washing and swelling: Weigh Wang-Lys (Dde) resin, add it to the peptide solid phase synthesis tube, weigh N,N-dimethylformamide (DMF) and add it to the peptide solid phase synthesis tube (the amount of solvent is based on the resin being evenly dispersed in the solvent. In general, the amount of solvent is 4.0-6.0eq of the resin, the same below), wash twice (N 2 Bubble, 1 min each time, and remove after washing); DMF, N 2Bubble for 30 minutes, and drain the liquid after full swelling; Coupling Fmoc-Leu-OH: Removal of Fmoc group, color development: Add 20% piperidine solution to the peptide solid phase synthesis tube, remove Fmoc twice (N 2 The bubbling time was 5 min and 7 min respectively, and the liquid was drained after the end), and washed 6 times with DMF (N 2 Bubble, 1 min each time, remove after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3 min; observe whether color is developed), detect the color change of resin; activation, coupling, color development, washing: on a synthetic scale N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Leu-OH (3.0eq), HBTU (3.0eq); add to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (3.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; room temperature 20-35℃, coupling reaction 0.5~1.0 hour; Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min; observe whether color is developed to determine whether the reaction is complete. If color is developed, continue coupling for 0.5 hour); drain the reaction solution, wash with DMF 3 times (N 2 Bubble, 1 min each time, and remove after washing); Repeat the above operation to couple Fmoc-Arg(Pbf)-OH according to the dosage in the material list; Removal of Fmoc group and color development: the same operation as before; shrinkage: add an appropriate amount of methanol to the peptide solid phase synthesis tube and shrink it 3 times (N 2 Bubbling: the time is 5min, 5min, and 10min respectively, and the liquid is drained after the end); drying: drying with nitrogen flow for 4.0~5.0h, until the resin particles are no longer sticky and are in the form of quicksand, Wang-Lys(Dde)-Leu-Arg(Pbf)-NH 2 Resin.
[0081] (2) Preparation of Fmoc-(1-6)-OH (2.1) Preparation of intermediate CTC-Leu, feed amounts are shown in Table 16: Table 16 Example 1 Preparation of intermediate CTC-Leu Feeding amount
[0082] Process: The preparation of CTC-Lys (Dde) is roughly the same as that of Comparative Example 1, wherein coupling: CTC resin molar amount N 0As the base, weigh Fmoc-Leu-OH, take an appropriate amount of DMF, add them to a beaker, stir to dissolve, and then add them to the peptide solid phase synthesis tube; weigh DIPEA and add it to the peptide solid phase synthesis tube; couple the reaction for 2.0-3.0h, remove the reaction solution, add DMF, and wash 3 times (N 2 Bubbling, 1 min each time, after which the liquid was drained off); CTC-Leu resin was obtained, and the substitution degree of CTC-Leu resin was detected to be 0.78 mmol / g.
[0083] (2.2) Preparation of Fmoc-(1-6)-OH, feed amounts are shown in Table 17: Table 17 Example 1 Preparation of Fmoc-(1-6)-OH Feed Amount
[0084] Process: washing and swelling: weigh CTC-Leu resin, add it to the peptide solid phase synthesis tube, weigh N,N-dimethylformamide (DMF) and add it to the peptide solid phase synthesis tube (the amount of solvent is based on the resin being evenly dispersed in the solvent. In general, the amount of solvent is 4.0-6.0eq of the resin, the same below), wash twice (N2 bubbling, 1 min each time, and remove after washing); add DMF to the peptide solid phase synthesis tube, bubble N2 for 30 min, and drain the liquid after sufficient swelling; coupling Fmoc-Glu(OtBu)-OH: remove Fmoc group, color development: add 20% piperidine solution to the peptide solid phase synthesis tube, remove Fmoc 2 times (N2 bubbling, time is 5min and 7min respectively, and the liquid is drained after the end), washed with DMF 6 times (N2 bubbling, 1min each time, and drained after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min; observe whether color is developed), detect the color change of resin; activation, coupling, color development, washing to synthesize scale N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-Glu(OtBu)-OH (3.0eq), HBTU (3.0eq); add to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (3.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; room temperature 20-35℃, coupling reaction 0.5~1.0 hour; Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min; observe whether color is developed to determine whether the reaction is complete. If color is developed, continue coupling for 0.5 hour); drain the reaction solution and wash with DMF 3 times (N2 bubbling, 1min each time, and drain after washing); Repeat the above steps to couple the following three amino acid fragments and Fmoc-PEG according to the dosage in the feed list. 4- Propionic acid fragment: coupling Fmoc-Trp(Boc)-OH; coupling Fmoc-Asn(Trt)-OH; coupling Fmoc-Arg(Pbf)-OH; coupling Fmoc-PEG 4 -Propionic acid.
[0085] Contraction: Add appropriate amount of methanol to the peptide solid phase synthesis tube and contract it 3 times (N2 bubbling, time is 5min, 5min, 10min respectively, and the liquid is drained after the end); Drying: Dry with nitrogen flow for 4.0~5.0h until the resin particles are no longer sticky and are in the form of quicksand, and CTC-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG is obtained. 4 -NH-Fmoc resin; cleavage; cleavage solution preparation: according to the ratio of 10ml / 1g resin, prepare the cleavage solution: (TFA: DCM = 1: 99v / v), mix well, and freeze to 5±5℃; ether pre-freeze: according to the ratio of 10ml / 1g resin, prepare the required ether, freeze it in a freezer for more than 2 hours, and set aside; add CTC-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG to the reaction bottle 4 -NH-Fmoc resin, slowly add the prepared pre-cooled cleavage solution under stirring, stir thoroughly, and perform cleavage reaction at room temperature of 20-30℃ for 2.0~3.0hr; filter and collect the filtrate. Wash the filter cake once with a small amount of cleavage solution. Combine the filtrates; concentrate the filtrate to dryness under reduced pressure in a water bath at <50℃, add frozen ether, precipitate the product, stir for 20min, filter, and add appropriate amount of frozen ether to fully wash more than 3 times; the obtained product is vacuum dried at room temperature of 20-30℃ for 6.0~7.0h to obtain the product Fmoc-(1-6)-OH, with a yield of 100.21%. The purity of the product is 81.824%.
[0086] NH 2 -PEG 4 Preparation of crude -RK(Dde)-OH, feed amounts are shown in Table 18: Table 18 Example 1 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0087] Process: Washing and swelling: weigh Wang-Lys(Dde)-Leu-Arg(Pbf)-NH 2The resin was added to the peptide solid phase synthesis tube, and N,N-dimethylformamide (DMF) was added to the peptide solid phase synthesis tube (the amount of solvent was based on the uniform dispersion of the resin in the solvent. Generally, the amount of solvent was 4.0-6.0eq of the amount of resin, the same below), and washed twice (N 2 Bubble, 1 min each time, and remove after washing); DMF, N 2 Bubble for 30 minutes, and drain the liquid after sufficient swelling; coupling Fmoc-(1-6)-OH: removal of Fmoc group, color development: add 20% piperidine solution to the peptide solid phase synthesis tube, remove Fmoc twice (N 2 The bubbling time was 5 min and 7 min respectively, and the liquid was drained after the end), and washed 6 times with DMF (N 2 Bubble, 1 min each time, remove after washing); Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3 min; observe whether color is developed), detect the color change of resin; activation, coupling, color development, washing: on a synthetic scale N 0 As the base number, weigh the materials according to a certain feeding ratio: Fmoc-(1-6)-OH (1.5eq), HATU (2.0eq) HAOt (2.0eq); add to a beaker, measure an appropriate amount of DMF, stir to dissolve, add DIPEA (2.0eq), activate the reaction for 3 minutes, and then add it to the peptide solid phase synthesis tube; room temperature 20-35℃, coupling reaction 0.5~1.0 hour; Kaiser method (take a small amount of resin, wash with DMF, add 3-5 drops of ninhydrin solution, heat at 120℃ for 3min; observe whether color is developed to determine whether the reaction is complete. If color is developed, continue coupling for 0.5 hour); drain the reaction solution, wash with DMF 3 times (N 2 Bubble, 1 min each time, and remove after washing); remove Fmoc group and color development: the operation is the same as before; shrink: add appropriate amount of methanol to the peptide solid phase synthesis tube, shrink 3 times (N 2 Bubbling: the time is 5min, 5min, and 10min respectively, and the liquid is drained after the end); drying: drying with nitrogen flow for 4.0~5.0h, until the resin particles are no longer sticky and are in the form of quicksand, and Wang-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG is obtained. 4 -NH 2 Resin; cleavage: cleavage solution preparation: according to the ratio of 10ml / 1g resin, prepare cleavage solution: (TFA: TIPS: H 2O=95:2.5:2.5v / v), mix well, and freeze to 5±5℃; pre-freeze ether: prepare the required ether according to the ratio of 70ml / 1g resin, freeze it in a freezer for more than 2 hours, and set aside; add Wang-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-Asn(Trt)-Arg(Pbf)-PEG to the reaction bottle 4 -NH 2 Resin, slowly add the prepared pre-cooled cleavage solution under stirring, stir thoroughly, and react at room temperature 20-30℃ for 2.0~3.0hr; filter and collect the filtrate. Wash the filter cake once with a small amount of cleavage solution. Combine the filtrates; add frozen ether (4-5ml ether / 1ml cleavage solution) to the reaction bottle, slowly add the filtrate under stirring to precipitate the product, stir for 20min, filter, and add appropriate amount of frozen ether to fully wash more than 3 times; the obtained product is vacuum dried at room temperature 20-30℃ for 6.0~7.0h to obtain NH 2 -PEG 4 -RK(Dde)-OH crude product, crude product yield: 103.88%, the crude product purity is: 80.896%.
[0088] NH 2 -PEG 4 Preparation of refined -RK(Dde)-OH, feed amount see Table 19: Table 19 Example 1 NH 2 -PEG 4 -RK(Dde)-OH refined product preparation feed amount
[0089] Purification conditions are the same as those in Comparative Example 1; Process: NH 2 -PEG 4 -RK(Dde)-OH crude product was dissolved and filtered: NH 2 -PEG 4 -RK(Dde)-OH crude product was ultrasonically dissolved with 200 ml diluent (90% mobile phase A-10% mobile phase B); a 0.22 µm microporous glass fiber filter was placed in the funnel, fully wetted, and NH 2 -PEG 4 -RK(Dde)-OH crude solution, connect the vacuum pump, open the control valve, filter, and replace the filter paper according to the actual situation. 2 -PEG 4 After the crude solution of -RK(Dde)-OH was filtered, 100 ml of diluent was added to the filter and filtered. 2 -PEG 4-RK(Dde)-OH crude solution was combined; sample loading: NH 2 -PEG 4 -RK(Dde)-OH crude solution loading; elution: linear gradient elution according to the purification gradient; sample collection: collect the target peak in sections (RK retention time is about 46min) and save the preparation chromatogram; merge: merge samples with purity less than 97.0% into repurified samples; concentration: merge and concentrate sample fractions with purity greater than 98.0%; freeze-drying: pack the merged target peptide solution into freeze-drying trays, each tray is 1.0~1.5 cm thick; the product enters the box, locks the box door, quickly freezes the product to below -45℃ and keeps it warm for 2 hours, turns on the vacuum pump to evacuate the front box, the vacuum degree is <50Pa, and sublimates according to the following curve: set the heat transfer oil to 0℃ in 2 hours and keep it for more than 12 hours; set the heat transfer oil to 25℃ in 2 hours and keep it for more than 6 hours; release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Sampling and packaging: release the vacuum, open the vacuum leak valve to release the vacuum in the box to normal pressure. Open the box door and quickly take out the freeze-dried plate from the box. Immediately take samples according to the sampling operation procedures after taking them out of the box. Transfer the drugs into low-density ethylene bottles for drug packaging. The total yield (Wang-Lys(Dde)-Leu-Arg(Pbf) resin→NH 2 -PEG 4 -RK(Dde)-OH refined product): 62.37%, labeled, sealed, and frozen for storage. The purity of the refined product is; 98.040%.
[0090] Example 2: Stepwise method B: Preparation of NH 2 -PEG 4 -RK(Dde)-OH Process route: Wang-(9-6)-NH 2 Preparation:
[0092] Preparation of Fmoc-(1-5)-OH:
[0093] NH 2 -PEG 4 Preparation of -RK(Dde)-OH:
[0094] (1) Wang-(9-6)-NH 2 Preparation (1.1) Preparation of the intermediate Wang-Lys(Dde)-OH, same as in Example 1: (1.2) Preparation of Wang-(9-6)-NH 2 , feed amount see Table 20: Table 20 Example 2 Wang-(9-6)-NH 2 Preparation feed amount
[0095] The process was the same as that in Example 1 to prepare Wang-(9-7)-NH 2 Wang-Lys(Dde)-Leu-Arg(Pbf)-Leu-NH 2 Resin.
[0096] (2) Preparation of Fmoc-(1-5)-OH The preparation method is roughly the same as that of Fmoc-(1-6)-OH in Example 1.
[0097] (2.1) Preparation of CTC-Glu(OtBu), feed amounts are shown in Table 21: Table 21 Example 2 Preparation of CTC-Glu (OtBu) Feeding Amount
[0098] CTC-Glu(OtBu) resin was obtained, and the substitution degree of CTC-Glu(OtBu) resin was detected to be 0.60 mmol / g.
[0099] (2.2) Preparation of Fmoc-(1-5)-OH, feed amounts see Table 22: Table 22 Example 2 Preparation of Fmoc-(1-5)-OH Feed Amount
[0100] The product Fmoc-(1-5)-OH was obtained with a yield of 100.66% and a product purity of 92.969%.
[0101] (3) NH 2 -PEG 4 Preparation of crude -RK(Dde)-OH The preparation method is the same as that of Example 1. 2 -PEG 4 -RK(Dde)-OH are roughly the same, and the feed amount is shown in Table 23: Table 23 Example 2 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0102] NH2 -PEG 4 -RK(Dde)-OH crude product, crude product yield: 101.10%, the crude product purity is: 91.266%.
[0103] (4) NH 2 -PEG 4 Preparation of refined product of -RK(Dde)-OH, purification conditions and process are the same as those in Comparative Example 1, wherein NH 2 -PEG 4 -RK(Dde)-OH crude product was dissolved in diluent and filtered, then loaded onto the sample, eluted according to the purification gradient, and the target peak was collected. The receiving solution with a purity greater than 98.0% was combined and concentrated under reduced pressure, and then divided into freeze-drying plates, and freeze-dried according to the freeze-drying curve. The freeze-dried samples were weighed, and the total yield (Wang-Lys(Dde)-Leu-Arg(Pbf)-Leu resin→NH 2 -PEG 4 -RK(Dde)-OH refined product): 76.81%, labeled, sealed, and frozen for storage. The purity of the refined product is; 99.602%.
[0104] Example 3 Stepwise Method C: Preparation of NH 2 -PEG 4 -RK(Dde)-OH Process route: Wang-(9-4)-NH 2 Preparation:
[0105] Preparation of Fmoc-(1-3)-OH:
[0106] NH 2 -PEG 4 Preparation of -RK(Dde)-OH:
[0107] (1) Wang-(9-4)-NH 2 Preparation: Preparation method and Example 1 Preparation of Wang-(9-7)-NH 2 The method is roughly the same, and the feed amount is shown in Table 24: Table 24 Example 3 Wang-(9-4)-NH 2 Preparation feed amount
[0108] Get Wang-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-NH 2 Resin.
[0109] (2) Preparation of Fmoc-(1-3)-OH The preparation method is roughly the same as that of Example 1 for preparing Fmoc-(1-6)-OH.
[0110] (2.1) Preparation of CTC-Asn(Trt), feed amounts are shown in Table 25: Table 25 Example 3 Preparation of CTC-Asn (Trt) Feeding Amount
[0111] CTC-Asn(Trt) resin was obtained, and the substitution degree of CTC-Asn(Trt) resin was detected to be 0.58 mmol / g.
[0112] (2.2) Preparation of Fmoc-(1-3)-OH, feed amounts see Table 26: Table 26 Example 3 Preparation of Fmoc-(1-3)-OH Feed Amount
[0113] The product Fmoc-(1-3)-OH was obtained in an amount of 22.08 g, with a yield of 101.32% and a product purity of 97.971%.
[0114] (3) NH 2 -PEG 4 Preparation of crude -RK(Dde)-OH Preparation method and Example 1 Preparation of NH 2 -PEG 4 -RK(Dde)-OH are roughly the same, and the feed amount is shown in Table 27: Table 27 Example 3 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0115] NH 2 -PEG 4 -RK(Dde)-OH crude product, crude product yield: 105.18%, the crude product purity is: 75.171%.
[0116] NH 2 -PEG 4 Preparation of refined -RK(Dde)-OH, feed amount see Table 28: Table 28 Example 3 NH 2 -PEG 4 -RK(Dde)-OH refined product preparation feed amount
[0117] The purification conditions and process are the same as those in Comparative Example 1, wherein NH 2 -PEG 4 -RK(Dde)-OH crude product was dissolved in diluent and filtered, then loaded and eluted according to the purification gradient. The target peak was collected, and the receiving solution with a purity greater than 98.0% was combined and concentrated under reduced pressure, then divided into freeze-drying plates and freeze-dried according to the freeze-drying curve. Wang-Lys(Dde)-Leu-Arg(Pbf)-Leu-Glu(OtBu)-Trp(Boc)-NH 2 Resin→NH 2 -PEG 4 The total yield of the refined product of -RK(Dde)-OH is 41.78%, which is labeled, sealed, and stored in a freezer. The purity of the refined product is 97.676%.
[0118] Example 4 Stepwise Method D: Preparation of NH 2 -PEG 4 -RK(Dde)-OH Process route: Wang-(9-7)-NH 2 Preparation: Same as Wang-(9-7)-NH 2 Preparation Preparation of Fmoc-(4-6)-OH:
[0119] Preparation of Fmoc-(1-3)-OH: the same as the preparation of Fmoc-(1-3)-OH in Example 3 NH 2 -PEG 4 Preparation of -RK(Dde)-OH:
[0120] (1) Wang-(9-7)-NH 2 Preparation The preparation method is shown in Example 1 Wang-(9-7)-NH 2 Preparation.
[0121] (2) Preparation of Fmoc-(4-6)-OH The preparation method is roughly the same as that of Fmoc-(1-6)-OH in Example 1, and the feed amounts are shown in Table 29: Table 29 Example 4 Preparation of Fmoc-(4-6)-OH Feed Amount
[0122] The product Fmoc-(4-6)-OH was obtained with a yield of 102.57% and a product purity of 95.888%.
[0123] (3) Preparation of Fmoc-(1-3)-OH The preparation method is shown in the preparation of Fmoc-(1-3)-OH in Example 3.
[0124] (4) NH 2 -PEG 4 Preparation of crude -RK(Dde)-OH Preparation method and implementation 1 NH 2 -PEG 4 The preparation of -RK(Dde)-OH is roughly the same, and the feed amounts are shown in Table 30: Table 30 Example 4 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0125] NH 2 -PEG 4 -RK(Dde)-OH crude product, crude product yield: 102.55%, the crude product purity is: 92.793%.
[0126] NH 2 -PEG 4 Preparation of refined -RK(Dde)-OH, feed amount see Table 31: Table 31 Example 4 NH 2 -PEG 4 -RK(Dde)-OH refined product preparation feed amount
[0127] The purification conditions and process are the same as those in Comparative Example 1, wherein NH 2 -PEG 4-RK(Dde)-OH crude product was dissolved in diluent and filtered, then loaded and eluted according to the purification gradient, the target peak was collected, the receiving solution with purity greater than 98.0% was combined and concentrated under reduced pressure, and then divided into freeze-drying trays, freeze-dried according to the freeze-drying curve, labeled, sealed, and stored in the freezer. Wang-Lys(Dde)-Leu-Arg(Pbf)-NH 2 Resin→NH 2 -PEG 4 The total yield of the refined product of -RK(Dde)-OH is 77.17%. The product is labeled, sealed and stored in a freezer. The purity of the refined product is 99.186%.
[0128] Example 5 Stepwise Method E: Preparation of NH 2 -PEG 4 -RK(Dde)-OH Process route Wang-(9-6)-NH 2 Preparation: Same as Wang-(9-6)-NH 2 Preparation Preparation of Fmoc-(4-5)-OH
[0129] Preparation of Fmoc-(1-3)-OH: the same as the preparation of Fmoc-(1-3)-OH in Example 3 NH 2 -PEG 4 Preparation of -RK(Dde)-OH
[0130] (1) Wang-(9-6)-NH 2 Preparation The preparation method is shown in Example 2 Wang-(9-6)-NH 2 Preparation.
[0131] (2) Preparation of Fmoc-(4-5)-OH The preparation method is roughly the same as that of Fmoc-(1-5)-OH in Example 2, and the feed amounts are shown in Table 32: Table 32 Example 5 Preparation of Fmoc-(4-5)-OH Feed Amount
[0132] The product Fmoc-(4-5)-OH was obtained with a yield of 100.92% and a product purity of 98.556%.
[0133] (3) Preparation of Fmoc-(1-3)-OH The preparation method is shown in Example 3 for the preparation of Fmoc-(1-3)-OH (4) NH 2 -PEG 4 Preparation of crude -RK(Dde)-OH Preparation method and NH in Example 1 2 -PEG 4 The preparation of -RK(Dde)-OH is roughly the same, and the feed amounts are shown in Table 33: Table 33 Example 5 NH 2 -PEG 4 -RK(Dde)-OH crude product preparation feed amount
[0134] NH 2 -PEG 4 -RK(Dde)-OH crude product, crude product yield: 102.00%, crude product purity: 85.159%.
[0135] (5) NH 2 -PEG 4 Preparation of refined RK(Dde)-OH The purification conditions and process are the same as those in Comparative Example 1, wherein NH 2 -PEG 4 The crude product of -RK(Dde)-OH was dissolved in diluent and filtered, then loaded on the sample, eluted according to the purification gradient, and the target peak was collected. The receiving solution with a purity greater than 98.0% was combined and concentrated under reduced pressure, and then divided into freeze-drying plates and freeze-dried according to the freeze-drying curve. CTC-Lys(Dde)→NH 2 -PEG 4 -RK(Dde)-OH refined product yield: 70.15%, label, seal, and store in a freezer. The refined product has a purity of 98.313%.
[0136] Example 1-5: Synthesis of NH by Segmentation 2 -PEG 4 -RK(Dde)-OH results are shown in Table 34: Table 34 Example 1-5 Segmented Synthesis of NH 2 -PEG 4 -RK(Dde)-OH Results Summary
[0137] NH 2 -PEG 4In the synthesis of -RK(Dde)-OH, since the amino acids at positions 2, 3, 4, and 5 carry consecutive protecting groups, it is easy to form a difficult sequence. In the process of coupling one by one, it is easy to form missing peptides and misconnected peptides, resulting in NH 2 -PEG 4 -RK(Dde)-OH crude product has more impurities.
[0138] From the above table, we can see that the segmented synthesis of NH 2 -PEG 4 -RK(Dde)-OH can overcome the difficult sequence and is a very effective method for improving the purity of the product; through the detection of crude products obtained by different segmentation methods, it was found that the 4+5 two-stage method B and the 3+3+3 three-stage method D have significant advantages, and the method is relatively easy to operate, and the purity of the obtained crude product is >90%. Purification of crude products obtained by different segmentation methods shows that the purity of the refined products after purification by segmentation methods B and D is >99.0%, and the total yield is also >75%. This method has low production cost, simple process and easy operation, and is suitable for industrial production.
[0139] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any technician familiar with the profession, without departing from the scope of the technical solution of the present invention, according to the technical essence of the present invention, any simple modification, equivalent replacement and improvement made to the above embodiment still falls within the protection scope of the technical solution of the present invention.
Claims
1. A method for synthesizing NH2-PEG4-RK(Dde)-OH, characterized in that: NH2-PEG4-RK(Dde)-OH is synthesized by a segmented synthesis method, wherein the segmented synthesis method is a two-stage method or a three-stage method; The two-stage method uses 5-Glu as a carbon terminal site to synthesize NH2-PEG4-RK(Dde)-OH through two synthetic fragments: fragment Wang-(9-6)-NH2 and fragment Fmoc-(1-5)-OH; The three-stage method uses 3-Asn and 6-Leu as two carbon terminal sites, respectively, so that NH2-PEG4-RK(Dde)-OH is synthesized through three synthetic fragments: fragment Wang-(9-7)-NH2, fragment Fmoc-(4-6)-OH, and fragment Fmoc-(1-3)-OH; The synthetic fragments are coupled via a condensing agent.
2. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 1, characterized in that: The fragment Wang-(9-6)-NH2 is synthesized by reacting Wang-Lys(Dde) with a protected amino acid, HBTU and DIPEA.
3. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 2, characterized in that: The Wang-Lys(Dde) synthesis method comprises reacting Wang resin with Fmoc-Lys(Dde)-OH, HOBt, DIC and DMAP.
4. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 1, characterized in that: The synthesis method of the fragment Fmoc-(1-5)-OH is to react CTC-Glu(OtBu) with protected amino acid, HBTU and DIPEA; after the reaction, the product is eluted with CTC resin lysis solution.
5. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 4, characterized in that: The synthesis method of CTC-Glu(OtBu) is to react CTC resin with Fmoc-Glu(OtBu)-OH and DIPEA.
6. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 1, characterized in that: The fragment Wang-(9-7)-NH2 is synthesized by reacting Wang-Lys(Dde) with a protected amino acid, HBTU and DIPEA.
7. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 1, characterized in that: The synthesis method of the fragment Fmoc-(4-6)-OH is to react CTC-Leu with protected amino acid, HBTU and DIPEA; after the reaction, CTC resin lysis solution is used to elute to obtain the product.
8. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 7, characterized in that: The synthesis method of CTC-Leu is to react CTC resin with Fmoc-Leu-OH and DIPEA.
9. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 1, characterized in that: The synthesis method of the fragment Fmoc-(1-3)-OH is to react CTC-Asn(Trt) with protected amino acid, HBTU and DIPEA; after the reaction, the product is eluted with CTC resin lysis solution.
10. The method for synthesizing NH2-PEG4-RK(Dde)-OH according to claim 9, characterized in that: The synthesis method of CTC-Asn(Trt) is to react CTC resin with Fmoc-Asn(Trt)-OH and DIPEA.
Citation Information
Patent Citations
Biosensor for electrochemically detecting HER2 and construction method of biosensor
CN108195913A
D-type polypeptide radiopharmaceutical of target HER2 and preparation method
CN109045313A
Rk polypeptide radiopharmaceutical targeting HER2 and preparation method thereof
CN110339375A
HER2-targeting rk polypeptide radiopharmaceutical and preparation method thereof
CN118267495A
Methods and intermediates for chemical synthesis of polypeptides and proteins
US20100234564A1
Cited By
Synthesis method of (S)-[2-(2-cyano-4, 4-difluoropyrrolidine-1-yl)-2-oxo-ethyl] tert-butyl carbamate
CN119409613A
